Meiling Su
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Toxicology top 10%
Papers in
-
- Advanced biosensing and bioanalysis techniques 3
- RNA Interference and Gene Delivery 2
- Surgery 6
- Co-authors
- Banghao Zhu (7 shared papers)Shuai Qian (11 shared papers)Yuanfeng Wei (7 shared papers)Yuan Gao (10 shared papers)Zongning Yin (6 shared papers)Wendong Huang (4 shared papers)Wai Ho Tang (5 shared papers)Weili Heng (6 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (3 papers)International Journal of Pharmaceutics (3 papers)Drug Delivery and Translational Research (2 papers)Pediatric Research (1 paper)Pharmaceutics (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Meiling Su
44 papers receiving 828 citations
Peers
Comparison fields: 5 of 96
- Pharmaceutical Science 126
- Toxicology 27
- Molecular Medicine 32
- Cancer Research 72
- Complementary and alternative medicine 40
Countries citing papers authored by Meiling Su
This map shows the geographic impact of Meiling Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Su more than expected).
Fields of papers citing papers by Meiling Su
This network shows the impact of papers produced by Meiling Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Su. The network helps show where Meiling Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiling Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 98 | |
| 2 | 2020 | 52 | |
| 3 | 2021 | 43 | |
| 4 | 2019 | 43 | |
| 5 | 2018 | 42 | |
| 6 | 2020 | 42 | |
| 7 | 2020 | 38 | |
| 8 | 2015 | 38 | |
| 9 | 2023 | 34 | |
| 10 | 2022 | 33 | |
| 11 | 2016 | 30 | |
| 12 | 2016 | 29 | |
| 13 | 2021 | 25 | |
| 14 | 2018 | 23 | |
| 15 | 2020 | 23 | |
| 16 | 2016 | 22 | |
| 17 | 2018 | 20 | |
| 18 | 2021 | 19 | |
| 19 | 2021 | 17 | |
| 20 | 2020 | 15 |
About Meiling Su
Meiling Su is a scholar working on Molecular Biology, Surgery, Pharmaceutical Science, Electrical and Electronic Engineering and Materials Chemistry, having authored 52 papers that have together received 839 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Diet, Metabolism, and Disease (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), RNA Interference and Gene Delivery (2 papers), Adipose Tissue and Metabolism (2 papers), Morinda citrifolia extract uses (2 papers) and Analytical Chemistry and Chromatography (2 papers). The work is most often cited by research in Pharmaceutical Science (126 citations), Toxicology (27 citations), Molecular Medicine (32 citations), Cancer Research (72 citations) and Complementary and alternative medicine (40 citations). Meiling Su has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Banghao Zhu, Shuai Qian, Yuanfeng Wei, Yuan Gao, Zongning Yin, Wendong Huang, Wai Ho Tang, Weili Heng, Yu He and John Hwa. Their work appears in journals such as Biochemical and Biophysical Research Communications, International Journal of Pharmaceutics, Drug Delivery and Translational Research, Pediatric Research and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.